Full Text Available

Note: Clicking the button above will open the full text document at the original institutional repository in a new window.

Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis

Saved in:
Bibliographic Details
Published in:Diabetes Therapy
Format: Online Article RSS Article
Published: 2026
Subjects:
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1867482859113021440
collection WordPress RSS
FRELIP Feed Integration
container_title Diabetes Therapy
description
discipline_display Hematology
discipline_facet Hematology
format Online Article
RSS Article
genre Journal Article
id rss_article:88956
institution FRELIP
journal_source_facet Diabetes Therapy
publishDate 2026
publishDateSort 2026
record_format rss_article
spellingShingle Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis
Hematology
General
Hematology
sub_discipline_display General
sub_discipline_facet General
subject_display Hematology
General
Hematology
Hematology
General
Hematology
subject_facet Hematology
General
Hematology
title Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis
title_auth Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis
title_full Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis
title_fullStr Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis
title_full_unstemmed Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis
title_short Dose–Response and Clinical Equivalence of Semaglutide and Tirzepatide for Weight Loss in Type 2 Diabetes: A Model-Based Analysis
title_sort dose–response and clinical equivalence of semaglutide and tirzepatide for weight loss in type 2 diabetes: a model-based analysis
topic Hematology
General
Hematology
url https://link.springer.com/article/10.1007/s13300-026-01886-0